{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:33:38Z","timestamp":1787646818108,"version":"build-2736575974"},"reference-count":38,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2022,1,4]]},"abstract":"<jats:p>Background: Alzheimer\u2019s disease (AD) is the progressive brain disorder which degenerates brain cells connection and causes memory loss. Although AD is irreversible, it is not impossible to arrest or slow down the progression of the disease. However, this would only be possible if the disease is diagnosed at an early stage, and early diagnosis requires clear understanding of the pathogenesis at molecular level. Overactivity of GSK-3\u03b2 and p53 accounts for tau hyperphosphorylation and the formation of amyloid-\u03b2 plaques. Objective: Here, we explored GSK-3\u03b2 and p53 as blood-based biomarkers for early detection of AD. Methods: The levels of GSK-3\u03b2, p53, and their phosphorylated states were measured using surface plasmon resonance and verified using western blot in serum from AD, mild cognitive impairment (MCI), and geriatric-control (GC) subjects. The neurotoxic SH-SY5Y cell line was treated with antioxidant Emblica Officinalis (EO) for rescue effect. Results: GSK-3\u03b2, p53, and their phosphorylated states were significantly over expressed (p\u200a&gt;\u200a0.001) in AD and MCI compared to GC and can differentiate AD and MCI from GC. The expression level of GSK-3\u03b2 and p53 proteins were found to be downregulated in a dose-dependent manner after the treatment with EO in amyloid-b-induced neurotoxic cells. Conclusion: These proteins can serve as potential blood markers for the diagnosis of AD and EO can suppress their level. This work has translational value and clinical utility in the future.<\/jats:p>","DOI":"10.3233\/jad-215347","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T11:10:25Z","timestamp":1636715425000},"page":"249-260","source":"Crossref","is-referenced-by-count":16,"title":["Circulatory GSK-3\u03b2: Blood-Based Biomarker and Therapeutic Target for Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"85","author":[{"given":"Shiwani","family":"Kumari","sequence":"first","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambica","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinay Kumar","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudhishthir","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Bajpai","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Datt","family":"Upadhyay","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Shekhar","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadanand","family":"Dwivedi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmistha","family":"Dey","sequence":"additional","affiliation":[{"name":"Department of Biophysics, All India Institute of Medical Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215347_ref1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000101306","article-title":"Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions","volume":"185","author":"Doble","year":"2007","journal-title":"Cells Tissues Organs"},{"key":"10.3233\/JAD-215347_ref2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2174\/156720512802455386","article-title":"Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease","volume":"9","author":"Cai","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-215347_ref3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","article-title":"Increased expression of the amyloid precursor \u03b2-secretase in Alzheimer\u2019s disease","volume":"51","author":"Holsinger","year":"2002","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-215347_ref4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2010.06.020","article-title":"SIRT1 suppresses \u03b2-amyloid production by activating the \u03b1-secretase gene ADAM10","volume":"142","author":"Donmez","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-215347_ref5","doi-asserted-by":"crossref","first-page":"e61560","DOI":"10.1371\/journal.pone.0061560","article-title":"Sirtuin1: A promising serum protein marker for early detection of Alzheimer\u2019s disease","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215347_ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid \u03b2-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-215347_ref7","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(01)00374-9","article-title":"Crystal structure of glycogen synthase kinase 3\u03b2: Structural basis for phosphate-primed substrate specificity and autoinhibition","volume":"105","author":"Dajani","year":"2001","journal-title":"Cell"},{"key":"10.3233\/JAD-215347_ref8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","article-title":"Neurodegenerative tauopathies","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-215347_ref9","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1073\/pnas.93.7.2719","article-title":"Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I\/glycogen synthase kinase 3\u03b2 in the brain","volume":"93","author":"Hoshi","year":"1996","journal-title":"U S A"},{"key":"10.3233\/JAD-215347_ref10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s40478-020-01012-6","article-title":"P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer\u2019s disease","volume":"8","author":"Farmer","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-215347_ref11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.10104","article-title":"Does p53 affect organismal aging?","volume":"192","author":"Donehower","year":"2002","journal-title":"J Cell Physiol"},{"key":"10.3233\/JAD-215347_ref12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2007.03.026","article-title":"p53 is upregulated in Alzheimer\u2019s disease and induces tau phosphorylation in HEK293a cells","volume":"418","author":"Hooper","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-215347_ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2009.11.078","article-title":"Induction of neuronal apoptosis by expression of Hes6 via a p53-dependent pathway","volume":"1313","author":"Eun","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215347_ref14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000329999","article-title":"Role of p53 in neurodegenerative diseases","volume":"9","author":"Chang","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-215347_ref15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/emboj\/20.7.1630","article-title":"COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system","volume":"20","author":"Bech-Otschir","year":"2001","journal-title":"EMBO J"},{"key":"10.3233\/JAD-215347_ref16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.cdd.4401925","article-title":"The complexity of p53 stabilization and activation","volume":"13","author":"Lavin","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.3233\/JAD-215347_ref17","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1089\/ars.2012.4713","article-title":"SirT1 regulation of antioxidant genes is dependent on the formation of a FoxO3a\/PGC-1\u03b1 complex","volume":"19","author":"Olmos","year":"2013","journal-title":"Antioxidants Redox Signal"},{"key":"10.3233\/JAD-215347_ref18","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1056\/NEJMcp0910237","article-title":"Clinical practice. Mild cognitive impairment","volume":"364","author":"Petersen","year":"2011","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-215347_ref19","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA work group* under the auspices of department of health and human services task force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.3233\/JAD-215347_ref20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.exger.2018.06.026","article-title":"Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer\u2019s disease-like pathology via maintaining oxidative balance through SIRT1 pathway","volume":"110","author":"Shekhar","year":"2018","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-215347_ref21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0891-0618(99)00012-5","article-title":"Developmental expression and localization of glycogen synthase kinase-3\u03b2 in rat brain","volume":"16","author":"Leroy","year":"1999","journal-title":"J Chem Neuroanat"},{"key":"10.3233\/JAD-215347_ref22","doi-asserted-by":"crossref","first-page":"11074","DOI":"10.1073\/pnas.190297597","article-title":"Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3\u03b2 in cellular and animal models of neuronal degeneration","volume":"97","author":"Bhat","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-215347_ref23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10508-006-9155-y","article-title":"Gender and sexual orientation differences in cognition across adulthood: Age is kinder to women than to men regardless of sexual orientation","volume":"36","author":"Maylor","year":"2007","journal-title":"Arch Sex Behav"},{"key":"10.3233\/JAD-215347_ref24","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1006\/bbrc.1997.6301","article-title":"Changes of p53 in the brains of patients with Alzheimer\u2019s disease","volume":"232","author":"Kitamura","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/JAD-215347_ref25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-215347_ref26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/NMM:3:3:159","article-title":"p53 is present in synapses where it mediates mitochondrial dysfunction and synaptic degeneration in response to DNA damage, and oxidative and excitotoxic insults","volume":"3","author":"Gilman","year":"2003","journal-title":"Neuromolecular Med"},{"key":"10.3233\/JAD-215347_ref27","doi-asserted-by":"crossref","first-page":"48872","DOI":"10.1074\/jbc.M305870200","article-title":"Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53","volume":"278","author":"Watcharasit","year":"2003","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-215347_ref28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-5-7","article-title":"GSK3 and p53 - Is there a link to Alzheimer\u2019s disease?","volume":"5","author":"Proctor","year":"2010","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-215347_ref29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejmech.2016.11.001","article-title":"Design, synthesis of allosteric peptide activator for human SIRT1 and its biological evaluation in a cellular model of Alzheimer\u2019s disease","volume":"127","author":"Kumar","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.3233\/JAD-215347_ref30","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","article-title":"Decreased plasma antioxidants in patients with Alzheimer\u2019s disease","volume":"21","author":"Kim","year":"2006","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215347_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5214\/ans.0972.7531.200101","article-title":"Neurodegeneration disorders need holistic care and treatment - Can Ayurveda meet the challenge?","volume":"20","author":"Lakhotia","year":"2013","journal-title":"Ann Neurosci"},{"key":"10.3233\/JAD-215347_ref32","first-page":"208","article-title":"An overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda","volume":"8","author":"Singh","year":"2011","journal-title":"African J Tradit Complement Altern Med"},{"key":"10.3233\/JAD-215347_ref33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/ptr.2195","article-title":"Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera","volume":"21","author":"Dhanasekaran","year":"2007","journal-title":"Phytother Res"},{"key":"10.3233\/JAD-215347_ref34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s13311-019-00767-8","article-title":"Neuroprotective and antioxidant effect of Ginkgo biloba extract against AD and other neurological disorders","volume":"16","author":"Singh","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.3233\/JAD-215347_ref35","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/jssc.200600532","article-title":"Separation and evaluation of the free radical-scavenging activity of phenol components of Emblica officinalis extract by using an HPTLC-DPPH\u22c5 method","volume":"30","author":"Pozharitskaya","year":"2007","journal-title":"J Sep Sci"},{"key":"10.3233\/JAD-215347_ref36","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.foodchem.2008.09.077","article-title":"Identification of bioactive compounds in Phyllanthus Emblica L. fruit and their free radical scavenging activities","volume":"114","author":"Luo","year":"2009","journal-title":"Food Chem"},{"key":"10.3233\/JAD-215347_ref37","first-page":"271","article-title":"The neuroprotective mechanism of cinnamaldehyde against amyloid-\u03b2 in neuronal SHSY5Y cell line: The role of N-methyl-D-aspartate, ryanodine, and adenosine receptors and glycogen synthase kinase-3\u03b2","volume":"9","author":"Emamghoreishi","year":"2019","journal-title":"Avicenna J Phytomed"},{"key":"10.3233\/JAD-215347_ref38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000449482","article-title":"Exploring the effect of Phyllanthus Emblica L. on cognitive performance, brain antioxidant markers and acetylcholinesterase activity in rats: Promising natural gift for the mitigation of Alzheimer\u2019s disease","volume":"23","author":"Uddin","year":"2016","journal-title":"Ann Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:47Z","timestamp":1777370687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":38,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-215347","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]}}}